The New England Journal of Medicine

News & Analysis

the new england journal of medicine - All News and Analysis

• Data Published in The New England Journal of Medicine Support Use of Raxibacumab for the Treatment of Inhalation Anthrax

  - 2009-07-09

  - Biologics License Application pending for first-in-class treatment for inhalation anthrax - - HGS has delivered 20,000 doses of raxibacumab to the U.S. Strategic National Stockpile for emergency use under a contract with BARDA - ROCKVILLE, Md., July 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. ...

  Tags: The New England Journal of Medicine

• SCAI Statement on the BARI 2D Trial Presented at the American Diabetes Association Annual Scientific Sessions and Published in The New England Journal of Medicine

  - 2009-06-07

  WASHINGTON, June 7 /PRNewswire/ -- BARI-2D is a useful and focused trial that builds on the body of scientific knowledge physicians use to provide the best possible care for diabetic patients with chronic stable angina and to evaluate their treatment options. The Society for Cardiovascular Angiography...

  Tags: The New England Journal of Medicine

• Drug-coated stents are just as good as bare-metal stents, but â?¦

  - 2009-06-01

  Drug-coated stents, intended to keep coronary arteries from closing up again, have been under suspicion for causing harm to people years after they had an artery-opening procedure. In earlier studies, the powerful drugs used to coat the tiny wire-mesh cylinders known as stents, were linked to a slightly...

  Tags: The New England Journal of Medicine

• Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap.

  - 2009-04-01

  VENLO, Netherlands, April 1 /PRNewswire/ -- - QIAGEN donates one million tests to expand access to HPV screening in the world's poorest countries Results from an eight-year trial involving more than 130,000 women published today in The New...

  Tags: The New England Journal of Medicine

• Clinical trials conducted overseas

  - 2009-03-16

  Most of the pharmaceutical industry's late-stage human clinical testing is done abroad, according to a study in The New England Journal of Medicine. The authors of the journal article found proper research oversight and adequate informed consent to be inconsistent in developing countries, where such tests are often...

  Tags: The New England Journal of Medicine

• Air quality in the United States

  - 2009-03-01

  Air Quality in the United States: The New England Journal of Medicine reports in their January 22, 2009 issue that since the 1970's, substantial efforts and investments have been made to improve air quality. It is reported that studies all support the view that reduction in long term...

  Tags: The New England Journal of Medicine

• Carefully selected kidney donors can expect to live just as long as people in the general population and experience no significant drop in kidney function, according to a report in The New England Journal of Medicine

  - 2009-02-02

  Carefully selected kidney donors can expect to live just as long as people in the general population and experience no significant drop in kidney function, according to a report in The New England Journal of Medicine (1/29). Prior research has supported the belief that kidney donation is safe,...

  Tags: The New England Journal of Medicine

• I want a new drug: pharmaceutical spending

  - 2009-02-01

  MARCIA ANGELL, former editor of The New England Journal of Medicine, has argued that Americans spend so much money on pharmaceuticals partly because many of the drugs people now take "are more likely to be expensive new ones instead of older, cheaper ones." But a new study from the Manhattan...

  Tags: The New England Journal of Medicine

• Vytorin and Zetia continue to be prescribed despite hints of harms and no proof of benefit

  - 2008-10-01

  There is no proof that Zetia can do anything beyond lowering cholesterol--no evidence that it can reduce heart attacks or cardiovascular disease, which, of course, is the ultimate goal. Once again, this blockbuster drug sold alone or as a combination medicine has produced negative clinical trial results. This time it...

  Tags: The New England Journal of Medicine

• Gene changes in five chromosome regions appear to have a combined effect for increasing the risk of prostate cancer, according to a report in The New England Journal of Medicine

  - 2008-01-21

  Gene changes in five chromosome regions appear to have a combined effect for increasing the risk of prostate cancer, according to a report in The New England Journal of Medicine (1/16). Previous reports have linked several of these changes or "variants" with prostate cancer, but with each variant,...

  Tags: The New England Journal of Medicine